Malo-Manso Alfredo, Fontaneda-Heredia Ana, Romero-Molina Salvador, Sepúlveda-Haro Enrique, Escalona-Belmonte Juan José, Guerrero-Orriach José Luis
Málaga´s Biomedical Institute (IBIMA), Málaga, Spain.
Hospital Universitano Virgen de la Victoria, Málaga, Spain.
Curr Med Chem. 2023;30(14):1667-1681. doi: 10.2174/0929867329666220907155612.
Opioid Free Anesthesia (OFA) is a relatively new technique that has been questioned due to the lack of evidence regarding its benefit-risk balance.
Four international databases were searched for clinical trials comparing OFA with opioid based anesthesia. The primary outcome was pain control and the secondary included postoperative nausea and vomiting (PONV), gastrointestinal recovery, respiratory depression, urinary retention, length of hospital stay, surgical complications, number of patients with cessation of the intervention and other side effects.
Pain was better controlled in the OFA group in all the measurements made (VAS 1h: Md = -0.81, CI95% = -0.48- -1.14, VAS 24h: Md = -1.25, CI95% =-2.41- -0.1, VAS >24h: Md = -1.36, CI95% = -1.73- -1). In the opioid group there was an increase in the risk of nausea (RR=2.69, CI95% = 2-3.61) and vomiting (RR = 3.99, CI95% = 2.06-7.74), whilst in the OFA group, there was an increased risk of bradycardia (RR= 1.62, CI95% = 1.02-2.57). The rest of the variables showed no differences between groups or could not be analyzed.
There is a clear benefit of OFA in pain control and PONV, but there is also a higher risk of bradycardia. This technique should be considered in patients with a special risk of difficult postoperative pain control or PONV. However, the best drug combination to perform OFA is still unknown, as well as the type of patient that benefits more with less risk.
无阿片类药物麻醉(OFA)是一种相对较新的技术,由于缺乏关于其利弊平衡的证据而受到质疑。
检索了四个国际数据库,以查找比较OFA与基于阿片类药物麻醉的临床试验。主要结局是疼痛控制,次要结局包括术后恶心和呕吐(PONV)、胃肠道恢复、呼吸抑制、尿潴留、住院时间、手术并发症、停止干预的患者数量以及其他副作用。
在所有测量中,OFA组的疼痛控制更好(VAS 1小时:中位数=-0.81,95%置信区间=-0.48至-1.14;VAS 24小时:中位数=-1.25,95%置信区间=-2.41至-0.1;VAS>24小时:中位数=-1.36,95%置信区间=-1.73至-1)。阿片类药物组恶心风险增加(相对风险=2.69,95%置信区间=2至3.61)和呕吐风险增加(相对风险=3.99,95%置信区间=2.06至7.74),而OFA组心动过缓风险增加(相对风险=1.62,95%置信区间=1.02至2.57)。其余变量在组间未显示差异或无法进行分析。
OFA在疼痛控制和PONV方面有明显益处,但也有较高的心动过缓风险。对于术后疼痛控制困难或PONV有特殊风险的患者,应考虑采用该技术。然而,实施OFA的最佳药物组合仍然未知,以及受益更多且风险更低的患者类型也未知。